ViaCyte Raises $80M to Prep for the Clinic Now, Perhaps an IPO Later

Submitted by admin on November 29, 2018 - 12:15am

Source:

Xconomy

News Tags:

ViaCyte

stem cells

diabetes

IPOs

clinical trials

Headline:

ViaCyte Raises $80M to Prep for the Clinic Now, Perhaps an IPO Later

snippet:

ViaCyte is recruiting patients for clinical trials testing its experimental stem cell-based diabetes treatment. Now it has $80 million to support that work, and also prepare for something more: a possible IPO.

Search form

You are here

ViaCyte Raises $80M to Prep for the Clinic Now, Perhaps an IPO Later

ViaCyte Raises $80M to Prep for the Clinic Now, Perhaps an IPO Later